View Single Post
Old 03-27-2011, 12:24 AM
Conductor71's Avatar
Conductor71 Conductor71 is offline
Senior Member
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Conductor71 Conductor71 is offline
Senior Member
Conductor71's Avatar
 
Join Date: Jul 2009
Location: Michigan
Posts: 1,474
10 yr Member
Default We have been following this one...

Quote:
Originally Posted by Nan Cyclist View Post
http://weill.cornell.edu/#id=30

This article just appeared in the Cornell Weill journal. I am just so hopeful.
Nan,

We have been sharing Neurologix updates here, and I am really hopeful too. I see this as easily supplanting DBS. It is interesting to note that Medtronic, the co, responsible for DBS design, plays a part in this treatment. It's almost as if they know Neurologix is really offering a superior treatment and are wanting to be a part of the deal.

Most articles I have read give very little detail on the procedure itself, but this article explains the newer bedside delivery innovation and the sham procedure. I have wondered how a sham surgery is performed; this is the first article I have read that clearly explains the sham surgery details. I have also read that the real deal will be given to the control group at the end of the study if they so opt to have it.

One of the lead researchers is my former neuro Dr. Lewitt, so I may be calling to see if I qualify for further trials.

Thanks for the extras!

Laura




Laura
Conductor71 is offline   Reply With QuoteReply With Quote